EYPT:NASDAQ
EyePoint Inc
3,23 $
arrow_downward
-1,22%(-0,040) 1D
3,30 $
arrow_upward
+2,17% (+0,070)todayPre-market
Closed: 1 қаз., 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EYPT...
Open
3,29 $
High
3,45 $
Low
3,23 $
Mkt. cap
278,47 млн
Avg. vol.
4,15 млн
Volume
776,00
52-wk high
19,01 $
52-wk low
3,23 $
EPS
-3,74 $
Beta
1,63
Shares outstanding
86,21 млн
No. of employees
214
Open
3,29 $
High
3,45 $
Low
3,23 $
Mkt. cap
278,47 млн
Avg. vol.
4,15 млн
Volume
776,00
52-wk high
19,01 $
52-wk low
3,23 $
EPS
-3,74 $
Beta
1,63
Shares outstanding
86,21 млн
No. of employees
214
News stories
From web sources and news partners
www.marketscreener.com
·
25 минут бұрын
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Seeking Alpha
·
24 минут бұрын
SPYM ETF: S&P 500 Monthly Dashboard For October
Investor's Business Daily
·
56 минут бұрын
Twilio To Join S&P 500 Index
Profile
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner.
In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc. Wikipedia
About EyePoint Inc
CEO-
Employees214
Founded2000
HeadquartersWatertown, Массачусетс, Америка Құрама Штаттары
SectorPharmaceutical industry
Websiteeyepoint.bio